Quamed

03/11/2025

Exciting News!

We’re thrilled to share that Washington DENGU will be joining QUAMED as Technical Deputy Director on a 0.5FTE basis starting November 1st!
Washington brings over 15 years of experience in pharmaceutical manufacturing and regulatory affairs, and continues to lead and shape Africa’s regulatory landscape actively. He brings in a wealth of experience, which includes coordination and leading of continental GMP inspections, regulatory harmonisation, pharmaceutical local production and building capacity for hundreds of regulators across Africa, all driven by a passion for ensuring access to safe, effective, and quality medicines.

At QUAMED, Washington will work closely with our team to strengthen quality assurance systems and advance our mission of improving global access to quality medicines.

Join us in welcoming Washington!

24/10/2025

We are proud that our courses have contributed to the professional development of the Autorité Congolaise de Réglementation Pharmaceutique staff. A great commitment from their side, with indispensable support from the DG, Dr Ntumba. We fully share VillageReach's belief that regulators are an essential part of the healthcare workforce. The only way the public can place trust in medicines is through a reliable regulatory authority. We are looking forward to future collaborations with ACOREP and with VillageReach.

VillageReach, through the Private Distributors project, believes that regulators are an essential part of the healthcare workforce and that ineffective regulatory systems can themselves be a barrier to access to quality, safe, and effective healthcare products. For nearly two months, we supported Ac...

24/10/2025

Access to essential medicines remains uneven worldwide. A study in India’s aspirational districts showed encouraging progress, with most treatments affordable and widely available. In stark contrast, Sudan’s civil war has led to severe shortages and unaffordable prices, leaving many without life-saving drugs. Meanwhile, Brazil continues to face systemic barriers, economic inequalities, import dependence, and limited R&D investment that restrict equitable access.

Together, these studies reveal that true progress toward “health for all” requires stronger systems, local production, and policies that make medicines both available and affordable for everyone.

Read these for more insights:

https://pubmed.ncbi.nlm.nih.gov/41089951

https://pubmed.ncbi.nlm.nih.gov/41094447

https://pubmed.ncbi.nlm.nih.gov/41088287

The policymakers should prioritize enhancing R&D investment, reducing dependency on international markets, strengthening regulatory frameworks, and improving health care system efficiency to ensure reliable access to essential medicines.

18/10/2025

Recrutement – Responsable Suivi, Évaluation, Redevabilité et Apprentissage (SERA)

L’UGP/Pharma à Dakar recrute un(e) Responsable SERA pour piloter le suivi, l’évaluation et l’apprentissage du projet de développement de l’industrie pharmaceutique locale. Profil recherché : Master en suivi-évaluation ou équivalent, minimum 5 ans d’expérience, excellentes compétences analytiques et rédactionnelles.

Date limite : 31 octobre 2025

Postulez ici :

1. CONTEXTE En 2024, le Sénégal a adopté un nouveau référentiel de politiques publiques dénommé “Agenda national de Transformation systémique du Sénégal ” pour un Sénégal souverain, juste et prospère. Cette ambition est traduite dans la Stratégie nationale de développement 2025-20...

17/10/2025

The World Health Organization (WHO) has issued a warning after detecting Diethylene Glycol (DEG) contamination in three oral liquid medicines, COLDRIF, Respifresh TR, and ReLife, linked to child fatalities in India. These products, commonly used for cold, flu, and cough relief, are toxic and potentially fatal, especially for children. While no exports have been reported, WHO urges all countries to remain vigilant, enhance market surveillance, and immediately report any suspicious products.

Avoid using these medicines and seek medical help if exposed.

Read more: https://www.who.int/news/item/13-10-2025-medical-product-alert-n-5-2025--substandard-(contaminated)-oral-liquid-medicines

Alert summaryThis WHO Medical Product Alert refers to three substandard (contaminated) oral liquid medicines identified in India and reported to WHO on 8 October 2025.The affected products are oral liquid medicines containing active ingredients commonly used to relieve symptoms of the common cold, f...

13/10/2025

A recent chapter titled “The Current Situation of Medicines Quality in Low- and Middle-Income Countries: New Challenges to be Addressed” (IntechOpen, 2025) sheds light on a growing global health concern: 10.5% of medicines worldwide are of poor quality, with the greatest impact seen in low- and middle-income countries. Harsh climates, weak regulatory systems, and fragmented supply chains contribute to the problem, jeopardising treatment for diseases like tuberculosis, malaria, and HIV/AIDS. The authors call for stronger regulatory frameworks, traceability systems, and collaboration across nations to ensure medicine quality and patient safety.

The role of Quamed is to validate suppliers so that we can make sure that those suppliers have the systems to ensure that the products that they supply are of assured quality.

Read more: https://www.intechopen.com/chapters/1215778

An estimated 10.5% of medicines worldwide are of poor quality, negatively impacting health, economies, and societies globally. This issue is particularly pronounced in low- and middle-income countries, where harsh climatic conditions and weaker regulatory frameworks exacerbate the problem...

03/10/2025

The Association des Pharmaciens de Madagascar is hosting the 31st Congress of the Indian Ocean Pharmaceutical Federation on November 20-21, 2025, in Antananarivo. Themed "Health and Nutrition

Read more:

L'Association des Pharmaciens de Madagascar organise le 31e Congrès de la Fédération pharmaceutique de l'océan Indien les 20 et 21 novembre 2025 à Antananarivo. Sur le thème « Santé et nutrition : défis pharmaceutiques, innovations et perspectives en matière de santé publique », cet év....

03/10/2025

Ethiopia has reached a major milestone in medicines regulation, achieving World Health Organization (WHO) Maturity Level 3 (ML3)! This recognition highlights the Ethiopian Food and Drug Authority’s commitment to ensuring that medicines and vaccines meet international standards of quality, safety, and efficacy. Ethiopia now joins eight other African countries in demonstrating strong, well-functioning regulatory systems that protect public health.

Read more:

Ethiopia has been formally recognized by the World Health Organization (WHO) for achieving Maturity Level 3 (ML3), placing it among nine African countries with this status in WHO’s global classification of national regulatory authorities.This milestone reflects the Ethiopian Food and Drug Authorit...

03/10/2025

Having a GSDP, GMP, or MQAS assessment is not just a box-ticking exercise; it is essential to ensure that your pharmaceutical systems meet internationally recognised standards of quality and safety. These assessments are critical for building trust, protecting patients, and strengthening your position in the market. The Quamed Quality Certification Program (QCP) is significant because it allows wholesalers and manufacturers to demonstrate their commitment to meeting World Health Organization (WHO) standards. By being certified, your establishment shows that it prioritises quality and reliability, opening the door to new opportunities with clients and partners who value excellence.

Several organizations have already achieved QCP certification, proving their commitment to quality and positioning themselves as trusted partners in the global market.

03/10/2025

Today in Kabul, the Quamed and Relief International team conducted our Barriers & Solutions Workshop, focused on how to best facilitate local procurement of quality medical products in Afghanistan. Internet was still offline, which impeded registered turnout, but we had vibrant interactive discussions with over 35 external participants, with an even mix between government authorities, local suppliers, and NGOs. We are excited about taking forward the great ideas from the session, particularly on more coordination between stakeholders to build a healthy local humanitarian supply market in the country!

22/09/2025

From September 9 to 11, 2025, we had the privilege of facilitating a World Health Organization (WHO) workshop in Brazzaville, Republic of the Congo, focused on capacity building in quality assurance for the Procurement of Medical Products.

Together with WHO AFRO, WHO HQ, and our QUAMED team, we worked with 25 participants from WHO regional and country offices to strengthen knowledge and skills on:

- Good Storage and Distribution Practices (GSDP)
- Product dossier short evaluation in line with MQAS requirements
- Quality assurance and risk management in medical product procurement
- Audits, inspections, and effective use of WHO tools

The workshop combined interactive sessions, practical exercises, and real-life case studies, including a hands-on GSDP self-assessment at the National Central Medical Store (CAMEPS). We sincerely thank CAMEPS for welcoming us and enabling this practical exercise. Feedback from participants was overwhelmingly positive, with particular appreciation for the practical exercises and engaging facilitation.

A big thank you to WHO for the opportunity to contribute to this important initiative. We look forward to future collaborations that will continue to strengthen quality assurance in healthcare systems.

19/09/2025

The following message is courtesy of Dr. Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium